Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Pravastatin--ocular side effects after a two year follow-up?

Behrens-Baumann W, Thiery J, Fieseler HG, Seidel D.

Lens Eye Toxic Res. 1990;7(3-4):311-8.

PMID:
2129219
2.

Clinical implications of new drugs for lowering plasma cholesterol concentrations.

Illingworth DR.

Drugs. 1991 Feb;41(2):151-60. Review. No abstract available.

PMID:
1709846
3.

Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.

Pan HY.

Eur J Clin Pharmacol. 1991;40 Suppl 1:S15-8. Review.

PMID:
1904355
4.

Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.

Chong PH, Seeger JD.

Pharmacotherapy. 1997 Nov-Dec;17(6):1157-77. Review.

PMID:
9399600
5.

If LDL-C is the answer...what was the question? What do the data really show?

Katholi RE, Deitrick CL, Hardiek KJ.

Heart Dis. 2001 Jan-Feb;3(1):2-13. Review.

PMID:
11975764
6.

The cataractogenic activity of chemical agents.

Gehring PJ.

CRC Crit Rev Toxicol. 1971 Sep;1(1):93-118. Review. No abstract available.

PMID:
4266286

Supplemental Content

Support Center